The association of hemodilution and transfusion of red blood cells with biochemical markers of splanchnic and renal injury during cardiopulmonary bypass

Anesthesia and Analgesia

Volumn 109, Issue 2, 2009, Pages 331-339

  Huybregts, Rien A J M ^a   De Vroege, Roel ^a   Jansen, Evert K ^a   Van Schijndel, Anne W ^a   Christiaans, Herman M T ^a   Van Oeveren, Willem ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID BINDING PROTEIN 2; LACTIC ACID; N ACETYL BETA GLUCOSAMINIDASE; ACETYLGLUCOSAMINIDASE; BIOLOGICAL MARKER; CREATINE; FATTY ACID BINDING PROTEIN;

ADULT; AGED; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; FEMALE; HEMATOCRIT; HEMODILUTION; HUMAN; HYPOXEMIA; KIDNEY ISCHEMIA; LACTATE BLOOD LEVEL; MALE; PRIORITY JOURNAL; SPLANCHNIC BLOOD FLOW; BLOOD; BLOOD GAS ANALYSIS; CRYOANESTHESIA; ISCHEMIA; KIDNEY DISEASE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; POSTOPERATIVE COMPLICATION;

ACETYLGLUCOSAMINIDASE; AGED; BIOLOGICAL MARKERS; BLOOD GAS ANALYSIS; CARDIOPULMONARY BYPASS; CREATINE; ERYTHROCYTE TRANSFUSION; FATTY ACID-BINDING PROTEINS; FEMALE; HEMATOCRIT; HEMODILUTION; HUMANS; HYPOTHERMIA, INDUCED; ISCHEMIA; KIDNEY DISEASES; LACTIC ACID; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; SPLANCHNIC CIRCULATION;

EID: 67849124433     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ane.0b013e3181ac52b2     Document Type: Article

References (35)

1. Crystal GJ, Rooney MW, Salem MR. Regional hemodynamics and oxygen supply during isovolemic hemodilution alone and in combination with adenosine-induced controlled hypotension. Anesth Analg 1988;67:211-218
2. Martinez-Pellus AE, Merino P, Bru M, Canovas J, Seller G, Sapina J, Fuentes T, Moro J. Endogenous endotoxemia of intestinal origin during cardiopulmonary bypass. Role of type of flow and protective effect of selective digestive decontamination. Intensive Care Med 1997;23:1251-1257
3. McSweeney ME, Garwood S, Levin J, Marino MR, Wang SX, Kardatzke D, Mangano DT, Wolman RL; Investigators of the Ischemia Research and Education Foundation; Multicenter Study of Perioperative Ischemia Research Group. Adverse gastrointestinal complications after cardiopulmonary bypass: can outcome be predicted from preoperative risk factors? Anesth Analg 2004;98:1610-1617
4. Lieberman J, Marks WH, Cohn S, Jaicks R, Woode L, Sacchettini J, Fischer B, Moller B, Burus G. Organ failure, infection, and the systemic inflammatory response syndrome are associated with elevated concentrations of urinary intestinal fatty acid binding protein: study of 100 consecutive patients in a surgical intensive care unit. J Trauma 1998;45:900
5. Lieberman JM, Sacchettini J, Marks C, Marks WH. Human intestinal fatty acid binding protein: report of an assay with studies in normal volunteers and intestinal ischemia. Surgery 1997;121:335-342
6. Holmes JH IV, Lieberman JM, Probert CB, Marks WH, Hill ME, Paull DL, Guyton SW, Sacchettini J, Hall RA. Elevated intestinal fatty acid binding protein and gastrointestinal complications following cardiopulmonary bypass: a preliminary analysis. J Surg Res 2001;100:192-196
7. Morariu AM, Loef BG, Aarts LP, Rietman GW, Rakhorst G, van Oeveren W, Epema AH. Dexamethasone: benefit and prejudice for patients undergoing on-pump coronary artery bypass grafting: a study on myocardial, pulmonary, renal, intestinal, and hepatic injury. Chest 2005;128:2677-2687
8. Pathi VL, Morrison J, MacPhaden A, Martin W, McQuiston AM, Wheatley DJ. Alterations in renal microcirculation during cardiopulmonary bypass. Ann Thorac Surg 1998;65:993-998
9. Mohammadi-Karakani A, Asgharzadeh-Haghighi S, Ghazi- Khansari M, Hosseini R. Determination of urinary enzymes as a marker of early renal damage in diabetic patients. J Clin Lab Anal 2007;21:413-417
10. Habib RH, Zacharias A, Schwann TA, Riordan CJ, Engloren M, Durham SJ, Shah A. Role of hemodilutional anemia and transfusion during cardiopulmonary bypass in renal injury after coronary revascularization: implications on operative outcome. Crit Care Med 2005;33:1749-1756
11. Engloren MC, Habib RH, Zacharias A, Schwann TA, Riordan CJ, Durham SJ. Effect of blood transfusion on long-term survival after cardiac operation. Ann Thorac Surg 2002;74:1180-1186
12. Tsai AG, Cabrales P, Intaglietta M. Microvascular perfusion upon exchange transfusion with stored red blood cells in normovolemic anemic conditions. Transfusion 2004;44:1626-1634
13. Rahman SH, Ammori BJ, Holmfield J, Larvin M, McMahon MJ. Intestinal hypoperfusion contributes to gut barrier failure in severe acute pancreatitis. J Gastrointest Surg 2003;7:26-35
14. Habib RH, Zacharias A, Schwann TA, Riordan CJ, Durham SJ, Shah A. Adverse effects of low hematocrit during cardiopulmonary bypass in the adult: should current practice be changed? J Thorac Cardiovasc Surg 2003;125:1438-1450
15. Mathew JP, Mackensen GB, Phillips-Bute B, Stafford-Smith M, Podgoreanu MV, Grocott HP, Hill SE, Smith PK, Blumenthal JA, Reves JG, Newman MF; Neurologic Outcome Research Group (NORG) of the Duke Heart Center. Effects of extreme hemodilution during cardiac surgery on cognitive function in the elderly. Anesthesiology 2007;107:577-584
16. Nickolas TL, O'Rourke MJ, Yang J, Sise ME, Canetta PA, Barasch N, Buchen C, Khan F, Mori K, Giglio J, Devarajan P, Barasch J. Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Ann Intern Med 2008;148:810-819
17. Scott BH, Seifert FC, Glass PSA, Grimson R. Blood use in patients undergoing coronary artery bypass surgery: impact of cardiopulmonary bypass pump, hematocrit, gender, age and body weight. Anesth Analg 2003;97:958-963
18. Despotis GJ, Filos KS, Zoys TN, Hogue CW Jr, Spitznagel E, Lappas DG. Factors associated with excessive postoperative blood loss and hemostatic transfusion requirements: a multivariate analysis in cardiac surgical patients. Anesth Analg 1996;82:13-21
19. Murphy GJ, Reeves BC, Rogers CA, Rizvi SI, Culliford L, Angelini GD. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation 2007;116:2544-2552
20. Rogers MAM, Blumberg N, Saint SK, Kim C, Nallamothu BK, Langa KM. Allogeneic blood transfusions explain increased mortality in women after coronary artery bypass graft surgery. Am Heart J 2006;152:1028-1034
21. Furnary AP, Wu YX, Hiratzka LF, Grunkemeier GL, Page US III. Aprotinin does not increase the risk of renal failure in cardiac surgery patients. Circulation 2007;116(11 suppl):I127-33
22. Scott KL, Lecak J, Acker JP. Biopreservation of red blood cell: past, present, and future. Transfus Med Rev 2005;19:127-142
23. Berezina TL, Zaets SB, Morgan C, Spillert CR, Kamiyama M, Spolarics Z, Deitch EA, Machiedo GW. Influence of storage on red blood cell rheological properties. J Surg Res 2002;102:6-12
24. Gorman Koch C, Li L, Sessler DI, Figueroa P, Hoeltge GA, Mihaljevic T, Blackstone E. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med 2008;358: 1229-1239
25. Wang F, Dupuis JY, Nathan H, Williams K. An analysis of the association between preoperative renal dysfunction and outcome in cardiac surgery. Chest 2003;124:1852-1862
26. Thakar CV, Liangos O, Yared JP, Nelson D, Piedmonte MR, Hariachar S, Paganini EP. ARF after open-heart surgery: influence of gender and race. Am J Kidney Dis 2003;41:742-751
27. Demers P, Elkouri S, Martineau R, Couturier A, Cartier R. Outcome with high blood lactate levels during cardiopulmonary bypass in adult cardiac operation. Ann Thorac Surg 2000;70:2082-2086
28. Levy B. Lactate and shock state: the metabolic view. Curr Opin Crit Care 2006;12:315-321
29. Landow L. Splanchnic lactate production in cardiac surgery patients. Crit Care Med 1993;21(2 supp):S84-91
30. Ranucci M, IsgròG, Romitti F, Mele S, Biagioli B, Giomarelli P. Anaerobic metabolism during cardiopulmonary bypass: predictive value of carbon dioxide derived parameters. Ann Thorac Surg 2006;81:2189-2195
31. Braun JP, Schroeder T, Buehner S, Jain U, Dopfmer U, Schuster J, Bas S, Schimke I, Dohmen PM, Lochs H, Konertz W, Spies C. Small-dose epoprostenol decreases systemic oxygen consumption and splanchnic oxygen extraction during normothermic cardiopulmonary bypass. Anesth Analg 2006;102:17-24
32. de Vroege R, Stooker W, van Oeveren W, Bakker EW, Huybregts RA, van Klarenbosch J, van Kamp GJ, Hack CE, Eijsman L, Wildevuur CRH. The impact of heparin coated circuits upon metabolism in vital organs: effect upon cerebral and renal function during and after cardiopulmonary bypass. ASAIO J 2005;51:103-109
33. Duebner LF, Hagino I, Schmitt K, Stamm C, Zurakowski D, Jonas RA. Effects of phenylephrine on cerebral blood flow and metabolism during cardiopulmonary bypass. J Cardiothorac Vasc Anesth 2004;18:423-428
34. O'Dwyer C, Woodson LC, Conroy BP, Lin CY, Deyo DJ, Uchida T, Johnston WE. Regional perfusion abnormalities with phenylephrine during normothermic bypass. Ann Thorac Surg 1997;63:728-735
35. Faulí A, Gomar C, Campistol JM, Alvarez L, Manig AM, Matute P. Kidney-specific proteins in patients receiving aprotinin at highand low-dose regimens during coronary artery bypass graft with cardiopulmonary bypass. Eur J Anaesthesiol 2005;22:666-671